Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
2022 · The Lancet · 395 citations
https://doi.org/10.1016/s0140-6736(22)00519-0
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
408
Citations
2
h-index
1
i10-index
Ravindra Kumar Sudarsi is an academic researcher. The author has contributed to research in topics: COVID-19 Clinical Research Studies & Malaria Research and Control & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 2, co-authored 6 publications.
Click to start Chat